Published in Cancer Weekly, March 9th, 2010
"This trial aimed to compare concomitant DG with sequential D -- >G. Patients were randomised to eight cycles of gemcitabine 1,000 mg/m2...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.